[1]赵清侠,许丽荣,杨 莹,等.原发性肝癌患者血清VEGF浓度与抑郁症发生的相关性研究[J].现代检验医学杂志,2017,32(06):96-98.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　ZHAO Qing-xia,XU Li-rong,YANG Ying,et al.Study on the Correlation between Serum VEGF Concentration and Major Depressive Disorder of Patients with Primary Liver Cancer[J].Journal of Modern Laboratory Medicine,2017,32(06):96-98.[doi:10.3969/j.issn.1671-7414.2017.06.001]
点击复制

原发性肝癌患者血清VEGF浓度与抑郁症发生的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第32卷
期数:
2017年06期
页码:
96-98
栏目:
论著
出版日期:
2017-12-25

文章信息/Info

Title:
Study on the Correlation between Serum VEGF Concentration and Major Depressive Disorder of Patients with Primary Liver Cancer
文章编号:
1671-7414(2017)06-096-03
作者:
赵清侠1; 许丽荣1; 杨 莹2; 韩 伟1; 吴志新1; 赵丽燕3
1.陕西省人民医院,西安 710068; 2.宝鸡市中医医院,陕西宝鸡 721001; 3.西安交通大学第二附属医院,西安 710004
Author(s):
ZHAO Qing-xia1; XU Li-rong1; YANG Ying2; HAN Wei1; WU Zhi-xin1; ZHAO Li-yan3
1.Shaanxi Provincial People's Hospital,Xi'an 710068,China; 2.Baoji Hospital of Traditional Chinese Medicine,Shaanxi Baoji 721001,China; 3.the Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710004,China
关键词:
原发性肝癌;  血管内皮生长因子;  抑郁症
分类号:
R735.7; R730.43
DOI:
10.3969/j.issn.1671-7414.2017.06.001
文献标志码:
A
摘要:
目的 探讨原发性肝癌患者血清血管内皮生长因子(vascular endothelial growth factor,VEGF)水平与抑郁症发生因素的相关性。方法采用回顾性分析研究,选取陕西省人民医院2015年9月～2016年9月收治的原发性肝癌患者43例,使用抑郁自评量表评定,分为抑郁组和非抑郁组,用ELISA试剂盒检测血清中VEGF水平,分析抑郁、年龄、性别因素与血清VEGF浓度关系。结果 发生抑郁患者血清中VEGF水平(86.21 ±19.52 pg/ml)明显高于未发生抑郁的患者(48.31 ±9.16 pg/ml),经t检验,差异有统计学意义(t=-2.968,P=0.005)。性别分组检测患者血清VEGF水平t=0.079,P=0.938; 不同年龄段分组检测患者的血清VEGF水平,经多组方差分析F=0.618,P=0.655,年龄和性别因素对于原发性肝癌血清中VEGF的水平,差异无统计学意义。结论 原发性肝癌发生抑郁的患者,与血清VEGF水平存在相关性,提示血清VEGF水平可能成为原发性肝癌预后检测指标,对此类患者及早进行心理干预,可能改善肿瘤并发抑郁患者的预后。
Abstract:
Abstract:Objective To investigate the correlation between serum vascular endothelial growth factor(VEGF)and the factors of depressionin patients with primary liver cancer(HCC).Methods Theretrospective analysis was about 43 cases of primary liver cancer patients of Shaanxi Provincial People's Hospital,from September 2015 to September 2016.The self-rating depression scale was used to evaluate the patients with depression and non-depression group.By ELISA kits,test VEGF levels,analysis of depression,age,gender and serum VEGF concentration.Results The level of VEGF in patients with depression was 86.21±19.52 pg/ml,which was significantly higher than that in patients without depression(48.31±9.16 pg/ml)by t test(t=-2.968,P=0.005).The levels of serum VEGF in patientswith different gender groups were measured by t test(t=0.079,P=0.938).And the serum levels of VEGF were measured in patients with different age groups by multiple sets of variance analysis(F=0.618,P=0.655).For age andgender,there was no significant difference in serum VEGF level between HCC.Conclusion By HCC,it was related between depression and the level of serum VEGF,and it suggests that serum level of VEGF may become the prognosis of primary liver cancer detection index for these patients.Giving psychological interventions earlier,may improve the prognosis of cancer patients with depression.

参考文献/References:

[1] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[2] 傅建琴,李 珰.肝癌患者焦虑与抑郁状况及影响因素分析[J].承德医学院学报,2010,27(4):367-369. Fu JQ,Li D.Analysis of conditions of hepatic cancer patients withanxiety and depression and inffluencing factors[J].J Chengde Med Coll,2010,27(4):367-369.
[3] 徐同磊,谢淑丽,王广义.肝癌细胞信号传导通路研究的最新进展[J].中国老年学杂志,2013,33(7):1724-1726. Xu TL,Xie SL,Wang GY.Thelatest prgress in the study of the signaltransduction pathqay of hematomas cell[J].Chinese Journal of Gerontology,2013,33(7):1724-1726.
[4] 向本旭,刘婷婷,孙芳龄,等.VEGF相关信号通路在血管新生中的研究进展[J].中国比较医学杂志,2015,25(12):81-86. Xiang BX,Liu TT,Sun FL,et al.Advance in research on VECF-related sjgnaling pathways in angiogenesis[J].Chinese Journal of Comparative Medicine,2015,25(12):81-86.
[5] Clark-Raymond A,Halaris A.VEGF and depression:A comprehensive assessment of clinical data[J].Journal of Psychiatric Research,2013:1080-1087.
[6] Clark-Raymond A,Meresh E,Hoppensteadt D,et al.Vascular endothelial growth factor:a potential diagnostic biomarker for major depression[J].Journal of Psychiatric Research,2014(59):22-27.
[7] Peng S,Wang Y,Peng H,et al.Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma[J].Hepatology,2014,60(4):1264-1277.
[8] 惠凌云,王 凌,张 琳,等.CHB患者疾病进程与抑郁程度及血清BDNF水平的相关性[J]. 现代检验医学杂志,2015,30(3):13-15. Hui LY,Wang L,Zhang L,et al.Correlation of the disease process,depression severity and serum levels of BDNF in patients with CHB[J].J Mod Lab Med,2015,30(3):13-15.
[9] Tsuchiya K,Asahina Y,Matsuda S,et al.Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors ofsurvival for advanced hepatocellular carcinoma[J].Cancer,2014,120(2):229-237.
[10] 李 兵,傅 尧,符义富,等.口腔鳞状细胞癌患者血清中CCL2和VEGF表达的初步研究[J].现代检验医学杂志,2017,32(4):64-66,71. Li B,Fu Y,Fu YF,et al.Preliminary study on the expression of CCL2 andVEGF in serum of patients with oral squamous cell carcinoma[J].J Mod Lab Med,2017,32(4):64-66,71.
[11] 张庆玉,朱珍珍,付建飞,等.复发性抑郁症患者治疗前后血管内皮生长因子水平变化及与临床疗效的相关性[J].浙江医学,2016,38(4):252-255. Zhang QY,Zhu ZZ,Fu JF,et al.Serum VEGF levels in realtion of clinicalfeatures and therapeutic effect of patients with recurrent depression[J].Zhejiang Medical Journal,2016,38(4):252-255.
[12] 梁宁林.原发性肝癌患者血清内脂素、血管内皮生长因子表达及意义[J].临床消化病杂志,2017,29(1):33-36. Liang NL.Expression and clinical significances of s-erum visfatin,VEGFin patients with primary liver cancer[J].Chin J Gastroenterol,2017,29(1):33-36.
[13] 陈乐微,徐胜前,富 静.基于生命意义角度的死亡教育干预在晚期肝癌并发肝性脑病患者护理中的应用研究[J].中国现代医生,2016,19(54):149-153. Chen LW,Xu SQ,Fu J.Application study of deach education intervention from the perspective of the meaning of life in the care of patiens with advanced hepatic cancer accompanied with hepatic encephalophy[J].China Modern Doctor,2016,19(54):149-153. 收稿日期:2017-08-03 修回日期:2017-09-22

相似文献/References:

[1]卓传尚,柳丽娟,周淑燕.AFP-L3和PIVKA-Ⅱ检测对高危人群良恶性肝病的鉴别诊断价值[J].现代检验医学杂志,2017,32(04):40.[doi:10.3969/j.issn.1671-7414.2017.04.011]
　ZHUO Chuan-shang,LIU Li-juan,ZHOU Shu-yan.Performance of Serum AFP-L3 and PIVKA-Ⅱ in Differential Diagnosis of Benign and Malignant Liver Disease in High Risk Population[J].Journal of Modern Laboratory Medicine,2017,32(06):40.[doi:10.3969/j.issn.1671-7414.2017.04.011]
[2]李 兵a,傅 尧a,符义富a,等.口腔鳞状细胞癌患者血清中CCL2和VEGF表达的初步研究[J].现代检验医学杂志,2017,32(04):64.[doi:10.3969/j.issn.1671-7414.2017.04.018]
　LI Binga,FU Yaoa,FU Yi-fua,et al.Preliminary Study on the Expression of CCL2 and VEGF in Serum of Patients with Oral Squamous Cell Carcinoma[J].Journal of Modern Laboratory Medicine,2017,32(06):64.[doi:10.3969/j.issn.1671-7414.2017.04.018]
[3]孙 林,胡三强,宋传涛.儿童感染性肺炎患者血液中炎症因子,ECP,EOS,IgE,VEGF及其受体检测与临床意义分析[J].现代检验医学杂志,2018,33(01):121.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　SUN Lin,HU San-qiang,SONG Chuan-tao.Detection of Inflammatory Factors,ECP,EOS,IgE,VEGF and Its Receptors in Children with Infectious Pneumonia[J].Journal of Modern Laboratory Medicine,2018,33(06):121.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[4]刘学芳,霍 豆,赵 茜,等.急性脑梗死患者血清VEGF,SAA和Lp-PLA2联合检测的临床研究[J].现代检验医学杂志,2018,33(04):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
　LIU Xue-fang,HUO-Dou,ZHAO-Qian,et al.Diagnostic Value of Combined Detection of VEGF,SAA and Lp-PLA2 for Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2018,33(06):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
[5]刘国振,陈秀余,张修欢.血清 miR-122-5p，miR-486-5p，AFP及 AFP-L3水平联合检测对原发性肝癌的诊断价值[J].现代检验医学杂志,2022,37(01):82.[doi:10.3969/j.issn.1671-7414.2022.01.017]
　LIU Guo-zhen,CHEN Xiu-yu,ZHANG Xiu-huan.Value of Combined Detection of Serum miR-122-5p, miR-486-5p, AFP and AFP-L3 Levels in the Diagnosis of Primary LiverCancer[J].Journal of Modern Laboratory Medicine,2022,37(06):82.[doi:10.3969/j.issn.1671-7414.2022.01.017]
[6]邢文静a,卢相琴,齐敬聪b,等.血清高尔基体糖蛋白73与MIF水平联合检测对原发性肝癌的诊断和预后价值研究[J].现代检验医学杂志,2022,37(02):66.[doi:10.3969/j.issn.1671-7414.2022.02.014]
　XING Wen-jinga,LU Xiang-qin,QI Jing-congb,et al.Study on the Diagnostic and Prognostic Value of Serum Golgiglycoprotein 73 Combined with MIF Level in Primary Liver Cancer[J].Journal of Modern Laboratory Medicine,2022,37(06):66.[doi:10.3969/j.issn.1671-7414.2022.02.014]
[7]齐 锐,王何斌,李 劲,等.原发性肝癌患者血清miR-196b 和miR-520f 表达水平及其临床诊断价值分析[J].现代检验医学杂志,2023,38(05):47.[doi:10.3969/j.issn.1671-7414.2023.05.009]
　QI Rui,WANG Hebin,LI Jing,et al.Expression and Clinical Diagnostic Value of Serum miR-196b and miR-520f in Primary Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2023,38(06):47.[doi:10.3969/j.issn.1671-7414.2023.05.009]

备注/Memo

备注/Memo:
基金项目:陕西省自然科学基金面上项目:2014JM2-3035。 作者简介:赵清侠(1973-),女,护理本科,主管护师,E-mail:294256309@qq.com。 通讯作者:赵丽燕(1975-),女,护理本科,公卫硕士,副主任护师,E-mail:1104924271@qq.com。
更新日期/Last Update: 2017-12-26